KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT KALVISTA PHARMACEUTICALS, INC.

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV)
Listen to this Section


$9.93
+0.1750 ( +2.32% ) 163.0K

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

Market Data


Open $9.93
Previous Close $9.75
Volume 163.0K
Market Cap $481.83M
Day Range $9.62 - $10.02
52 Week Range $7.30 - $16.88
Shares Outstanding 49.42M
Change % +2.32%
Net Change ▲ 0.1750
Insider Ownership -0.03%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
IPO Year 2015
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -568,118.00

Date Type Amount Purchased Purchaser
2024-06-10 Sale -15625.00 Palleiko Benjamin L
2024-05-24 Sale -80000.00 Audhya Paul K.
2024-05-24 Sale -50000.00 Yea Christopher
2024-05-21 Sale -51031.00 Palleiko Benjamin L
2024-05-21 Sale -18789.00 Yea Christopher
2024-05-21 Sale -18789.00 Feener Edward P.
2024-05-21 Sale -30614.00 Audhya Paul K.
2024-04-22 Sale -17000.00 Fairey William
2024-03-08 Sale -250000.00 Palleiko Benjamin L
2024-02-22 Buy 655738.00 Venrock Healthcare Capital Partners III, L.P.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Dec 16, 2024
4 Insider transactions 1 Dec 09, 2024
8-k 8K-related 12 Dec 05, 2024
10-q Quarterly Reports 47 Dec 05, 2024
4 Insider transactions 1 Nov 27, 2024
4 Insider transactions 1 Nov 27, 2024
4 Insider transactions 1 Nov 26, 2024
3 Insider transactions 2 Nov 26, 2024
8-k 8K-related 14 Nov 26, 2024
4 Insider transactions 1 Nov 19, 2024

Latest News


× Before browsing our site, please accept our cookies policy